Skip to main content
OpenTrials

Clinical trial condition

Melanoma, Cutaneous Malignant

Explore clinical trials studying Melanoma, Cutaneous Malignant. Study availability and eligibility vary by location and protocol.

15 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Melanoma, Cutaneous Malignant trial results

Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

NCT06743126

Conditions
Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 71 locations
View Trial Details
Active, not recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, not recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

NCT05585320

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +29 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 20 locations
View Trial Details
Completed

A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

NCT06208124

Conditions
Adenocarcinoma, Advanced Solid Tumor (Phase 1), Bronchial Neoplasms, +25 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

NCT01748448

Conditions
Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations
  • Universitair Ziekenhuis Antwerpen, Dermatology Edegem, Belgium
  • UZLeuven Gasthuisberg Leuven, Belgium
  • Chef de Service du Service Universitaire de Dermatologie Liège, Belgium
  • Dep. of Dermatology, Medical and Health Science Center University of Debrecen Debrecen, Hungary
View Trial Details

Related conditions